Affiliation:
1. Institute of Cardiovascular and Medical Sciences, University of Glasgow, U.K.
2. Queen Elizabeth University Hospital, Glasgow, U.K.
3. Queen’s Medical Research Institute, University of Edinburgh, U.K.
Abstract
Background: Hypertension is prevalent in chronic kidney disease (CKD). Studies suggest that reduction in dietary salt intake reduces blood pressure (BP). We studied relationships between salt intake, BP and renin–angiotensin system regulation in order to establish if it is disordered in CKD.
Methods: Mechanistic crossover study of CKD patients versus non-CKD controls. Participants underwent modified saline suppression test prior to randomization to either low or high salt diet for 5 days and then crossed over to the alternate diet. Angiotensin-II stimulation testing was performed in both salt states. BP, urea and electrolytes, and plasma aldosterone concentration (PAC) were measured.
Results: Twenty-seven subjects were recruited (12 CKD, 15 control). There was no difference in age and baseline BP between the groups. Following administration of intravenous saline, systolic BP increased in CKD but not controls (131 ± 16 to 139 ± 14 mmHg, P=0.016 vs 125 ± 20 to 128 ± 22 mmHg, P=0.38). Median PAC reduced from 184 (124,340) to 95 (80,167) pmol in controls (P=0.003), but failed to suppress in CKD (230 (137,334) to 222 (147,326) pmol (P=0.17)). Following dietary salt modification, there was no change in BP in either group. Median PAC was lower following high salt compared with low salt diet in CKD and controls. There was a comparable increase in systolic BP in response to angiotensin-II in both groups.
Discussion: We demonstrate dysregulation of aldosterone in CKD in response to salt loading with intravenous saline, but not to dietary salt modification.
Reference53 articles.
1. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N. Engl. J. Med.,2004
2. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare Population, 1998 to 1999;Foley;J. Am. Soc. Nephrol.,2005
3. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials;Turnbull;Lancet,2003
4. Intensive blood-pressure control in hypertensive chronic kidney disease;Appel;N. Engl. J. Med. Massachusetts Med. Soc.,2010
5. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;N. Engl. J. Med.,2001
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献